CC
CL icon

ClearArc Capital’s Colgate-Palmolive CL Stock Holding History

ClearArc Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$630K Sell
9,145
-3,782
-29% -$258K 0.25% 102
2019
Q3 		$950K Buy
12,927
+123
+1% +$8.92K 0.27% 87
2019
Q2 		$918K Sell
12,804
-1,640
-11% -$116K 0.27% 88
2019
Q1 		$990K Sell
14,444
-441
-3% -$28.5K 0.27% 91
2018
Q4 		$886K Sell
14,885
-7,558
-34% -$473K 0.27% 91
2018
Q3 		$1.5M Buy
22,443
+106
+0.5% +$7.06K 0.2% 119
2018
Q2 		$1.45M Sell
22,337
-21
-0.1% -$1.37K 0.2% 114
2018
Q1 		$1.6M Sell
22,358
-6
-0% -$432 0.24% 101
2017
Q4 		$1.69M Sell
22,364
-269
-1% -$19.6K 0.23% 101
2017
Q3 		$1.65M Buy
22,633
+964
+4% +$69.5K 0.25% 95
2017
Q2 		$1.61M Buy
21,669
+90
+0.4% +$6.68K 0.26% 95
2017
Q1 		$1.58M Sell
21,579
-38
-0.2% -$2.66K 0.26% 97
2016
Q4 		$1.42M Sell
21,617
-209
-1% -$14.3K 0.25% 103
2016
Q3 		$1.62M Buy
21,826
+130
+0.6% +$9.61K 0.31% 84
2016
Q2 		$1.59M Sell
21,696
-68
-0.3% -$4.84K 0.31% 82
2016
Q1 		$1.54M Sell
21,764
-159
-0.7% -$10.6K 0.33% 75
2015
Q4 		$1.46M Buy
21,923
+80
+0.4% +$5.32K 0.31% 82
2015
Q3 		$1.39M Buy
21,843
+798
+4% +$52.1K 0.29% 91
2015
Q2 		$1.38M Buy
21,045
+2,563
+14% +$174K 0.25% 105
2015
Q1 		$1.28M Buy
18,482
+218
+1% +$15.1K 0.26% 107
2014
Q4 		$1.26M Buy
18,264
+514
+3% +$34.7K 0.26% 119
2014
Q3 		$1.16M Sell
17,750
-1,088
-6% -$71.8K 0.26% 118
2014
Q2 		$1.28M Buy
18,838
+207
+1% +$13.9K 0.3% 102
2014
Q1 		$1.21M Buy
18,631
+1,598
+9% +$101K 0.3% 96
2013
Q4 		$1.11M Sell
17,033
-231
-1% -$14.8K 0.29% 101
2013
Q3 		$1.02M Buy
17,264
+405
+2% +$24K 0.29% 106
2013
Q2 		$966K Buy
+16,859
New +$1M 0.26% 115

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ClearArc Capital's CL Position: Q4 2019 in Review

ClearArc Capital reduced its Colgate-Palmolive (CL) stake by 29% in Q4 2019, selling an estimated $258K and leaving 9,145 shares worth $630K. The position accounts for 0.25% of the portfolio, ranked #102.

ClearArc Capital first reported a position in CL in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.69M in Q4 2017. 1,510 funds tracked by Wall St. Rank hold CL as of Q4 2019.

  • ClearArc Capital held 9,145 shares of Colgate-Palmolive worth $630K as of Q4 2019.
  • ClearArc Capital sold 3,782 Colgate-Palmolive shares in Q4 2019, an estimated $258K.
  • Colgate-Palmolive made up 0.25% of ClearArc Capital's portfolio in Q4 2019, its #102 holding.
  • ClearArc Capital first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 27 quarters since.
  • ClearArc Capital's Colgate-Palmolive position peaked at $1.69M in Q4 2017.
  • 1,510 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.